Progress in Neuro-Psychopharmacology and Biological Psychiatry
Volume 17, Issue 5, September 1993, Pages 765-774
A preliminary trial of ascorbic acid as supplemental therapy for autism
References (22)
- et al.
A scale for rating symptoms of patients with the syndrome of autism in real life settings
J. Amer. Acad. Child Psychiat.
(1986) - et al.
Studies of 3-H dopamine in neostriatal membrane preparations: Effects of ascorbic acid
Life Science
(1983) - et al.
Ascorbic acid and the binding of DA agonists to neostriatal membrane preparations
Neurophannacol
(1983) - et al.
Inhibition of dopamine D-1 and D-2 binding sites in neuronal tissues by ascorbate
Neuropharmacol
(1981) - et al.
Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigrostriatal lesions
Brain Res. Bull.
(1979) - et al.
Effects of ascorbic acid on neurochemical, behavioral, and physiological systems mediated by catecholamines
Life Science
(1979) Megavitamin and Orthomolecular Therapy in Psychiatry
Nutri. Rev.
(1974)- et al.
Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms
Amer. J. Psychiat.
(1984) - et al.
Pharmacology of 3H-apomorphine binding to bovine brain tissue
Biochem. Pharmacol.
(1981) Drug treatment of infantile autism: The post decade
Psychopharmacology in child and adolescent psychiatry
J. Amer. Acad. Child and Adoles. Psychiat.
(1988)
Cited by (0)
Copyright © 1993 Published by Elsevier Inc.